心肌细胞Regnase-1降解细胞因子mRNA抑制压力过载心脏无菌性炎症
该研究在心肌细胞特异性Regnase-1缺陷小鼠中发现,压力过载4周后出现严重炎症和扩张型心肌病,Il6 mRNA上调;抗IL-6受体抗体或AAV9介导Regnase-1过表达可减轻野生型小鼠 severe压力过载诱导的心肌病,提示Regnase-1通路是心衰治疗靶点。
要点
- 心肌细胞Regnase-1缺失在基线无表型,压力过载后加剧炎症和扩张型心肌病。
- Regnase-1缺陷心脏中Il6 mRNA选择性上调,抗IL-6受体抗体可减轻病变。
- AAV9介导Regnase-1过表达或抗IL-6受体抗体可减轻野生型小鼠压力过载心肌病。
核心结论
- 心肌细胞Regnase-1降解细胞因子mRNA对抑制衰竭心脏无菌性炎症起重要作用。
- Regnase-1介导的通路可能成为心力衰竭的治疗靶点。
研究设计与样本
- 研究生成心肌细胞特异性Regnase-1缺陷小鼠,并进行横向主动脉缩窄诱导压力过载。
- 术后4周通过超声心动图、组织学和分子分析评估心脏重构,免疫染色检查炎症细胞浸润。
- 通过抗IL-6受体抗体抑制IL-6信号,并通过腺相关病毒载体介导Regnase-1心脏过表达。
主要发现
- 心肌细胞特异性Regnase-1缺陷小鼠在基线条件下无心脏表型。
- 压力过载4周后,Regnase-1缺陷小鼠较对照同窝仔鼠出现严重炎症和扩张型心肌病。
- 横向主动脉缩窄4周后,Regnase-1缺陷心脏中Il6 mRNA水平上调,但包括肿瘤坏死因子-α在内的其他细胞因子mRNA未上调。
- 术后1周Regnase-1缺陷和对照心脏Il6 mRNA水平均升高,但术后4周对照心脏未见升高。
- 在严重压力过载的野生型小鼠心脏中,即使Regnase-1蛋白水平升高,仍观察到Il6 mRNA持续诱导。
临床怎么用
- 抗IL-6受体抗体可减轻心肌细胞特异性Regnase-1缺陷小鼠的炎症和心肌病发展。
- AAV9介导心肌细胞靶向Regnase-1基因递送或抗IL-6受体抗体给药可减轻野生型小鼠严重压力过载诱导的心肌病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Proinflammatory cytokines play an important role in the pathogenesis of heart failure. The mechanisms responsible for maintaining sterile inflammation within failing hearts remain poorly defined. Although transcriptional control is important for proinflammatory cytokine gene expression, the stability of mRNA also contributes to the kinetics of immune responses. Regnase-1 is an RNase involved in the degradation of a set of proinflammatory cytokine mRNAs in immune cells. The role of Regnase-1 in nonimmune cells such as cardiomyocytes remains to be elucidated. METHODS: To examine the role of proinflammatory cytokine degradation by Regnase-1 in cardiomyocytes, cardiomyocyte-specific Regnase-1-deficient mice were generated. The mice were subjected to pressure overload by means of transverse aortic constriction to induce heart failure. Cardiac remodeling was assessed by echocardiography as well as histological and molecular analyses 4 weeks after operation. Inflammatory cell infiltration was examined by immunostaining. Interleukin-6 signaling was inhibited by administration with its receptor antibody. Overexpression of Regnase-1 in the heart was performed by adeno-associated viral vector-mediated gene transfer. RESULTS: Cardiomyocyte-specific Regnase-1-deficient mice showed no cardiac phenotypes under baseline conditions, but exhibited severe inflammation and dilated cardiomyopathy after 4 weeks of pressure overload compared with control littermates. Four weeks after transverse aortic constriction, the Il6 mRNA level was upregulated, but not other cytokine mRNAs, including tumor necrosis factor-α, in Regnase-1-deficient hearts. Although the Il6 mRNA level increased 1 week after operation in both Regnase-1-deficient and control hearts, it showed no increase in control hearts 4 weeks after operation. Administration of anti-interleukin-6 receptor antibody attenuated the development of inflammation and cardiomyopathy in cardiomyocyte-specific Regnase-1-deficient mice. In severe pressure overloaded wild-type mouse hearts, sustained induction of Il6 mRNA was observed, even though the protein level of Regnase-1 increased. Adeno-associated virus 9-mediated cardiomyocyte-targeted gene delivery of Regnase-1 or administration of anti-interleukin-6 receptor antibody attenuated the development of cardiomyopathy induced by severe pressure overload in wild-type mice. CONCLUSIONS: The degradation of cytokine mRNA by Regnase-1 in cardiomyocytes plays an important role in restraining sterile inflammation in failing hearts and the Regnase-1-mediated pathway might be a therapeutic target to treat patients with heart failure.
引用
- Omiya S, Omori Y, Taneike M, et al. Cytokine mRNA Degradation in Cardiomyocytes Restrains Sterile Inflammation in Pressure-Overloaded Hearts. Circulation. 2020. PMID: 31931613. doi:10.1161/CIRCULATIONAHA.119.044582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。